Health Care & Life Sciences » Pharmaceuticals | Clinuvel Pharmaceuticals Ltd.

Clinuvel Pharmaceuticals Ltd. | Cash Flow

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
5,525.90
10,414.40
3,153.70
7,114.30
13,224.20
Depreciation, Depletion & Amortization
37.50
26.50
25.50
53.10
44.50
Other Funds
-
-
89.10
85.10
-
Funds from Operations
5,220.10
4,678.90
1,750.60
7,637.30
13,079.90
Changes in Working Capital
411.40
149.10
3,286.40
2,279.60
1,386.60
Net Operating Cash Flow
4,808.70
4,529.80
5,036.90
9,916.90
11,693.30
Capital Expenditures
3.40
12.10
98.10
67.50
75.10
Sale of Fixed Assets & Businesses
-
1.40
-
-
-
Net Investing Cash Flow
3.40
10.70
98.10
67.50
75.10
Net Financing Cash Flow
6,881.80
222.70
8,388.40
85.10
-
Net Change in Cash
2,056.70
4,053.30
3,272.40
9,907.60
12,446.10
Free Cash Flow
4,812.10
4,541.90
5,135.00
9,849.50
11,618.20
Deferred Taxes & Investment Tax Credit
-
-
-
-
281.80
Change in Capital Stock
6,881.80
222.70
8,299.20
-
-
Exchange Rate Effect
12.90
264.50
19.00
26.90
827.90

About Clinuvel Pharmaceuticals

View Profile
Address
15 Queen Street
Melbourne Victoria (VIC) 3000
Australia
Employees -
Website http://www.clinuvel.com
Updated 07/08/2019
Clinuvel Pharmaceuticals Ltd. is a global biopharmaceutical company. It engages in the the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.